Mevo Secures $19M Series B to Revolutionize Digital Prescriptions in Brazil

Mevo Secures $19M Series B to Revolutionize Digital Prescriptions in Brazil Key Takeaways: Mevo, a Brazilian digital prescription platform, raised $19 million in a Series B funding round led by Matrix Partners. The funding will be used to expand Mevo's network of healthcare provider partners, enhance its platform, and explore new healthcare services. Mevo aims to solve the problem of paper-based prescriptions in Brazil, which contribute to unfilled prescriptions and poor health outcomes. Mevo's Solution and Impact: Mevo provides a digital platform that allows healthcare providers in Brazil to issue digital prescriptions. Patients can then use these prescriptions to purchase medications at any pharmacy, including Mevo's own online marketplace. This system offers several benefits: Improved patient experience and medication adherence: Patients can easily access their prescriptions and purchase medications with just a few clicks on their mobile devices. Increased access to healthcare: Mevo's platform makes it easier for patients to get the medication they need, regardless of their location. Reduced errors and improved efficiency: Digital prescriptions reduce the risk of errors associated with handwritten prescriptions and streamline the prescription process. Quotes of Note: Pedro Dias, CEO and co-founder of Mevo: "This investment will allow us to expand our network and introduce new product offerings that continue to improve the customer experience... We're focused on offering Brazilians a better way to access healthcare." John Loser, co-founder and General Partner, Floating Point: "From day one, the Mevo team has shown the vision and grit necessary to create a core piece of digital infrastructure for the entire Brazilian healthcare system." TJ Parker, Partner at Matrix Partners: "Mevo is addressing a critical need in the Brazilian healthcare market: modernizing and digitizing the way people access prescriptions... I'm inspired by their focus on the customer experience and dedication to making it simple for people in Brazil to get the healthcare they need." Investor Interest and Future Growth: The Series B funding round highlights significant investor confidence in Mevo's potential to transform the Brazilian healthcare market. With a strong foundation of over 10 million patients and partnerships with all Brazilian pharmacies, Mevo is well-positioned to become a leading player in the digital healthcare space. Further Information: Mevo was founded in 2017 and is headquartered in São Paulo, Brazil. The company has raised a total of $19 million in funding to date. Mevo's investors include Matrix Partners, Jefferson River Capital, Floating Point, and IKJ Capital.